ZAIDYN Insights

Patient support programs generate vast amounts of data, but many life sciences companies still struggle to turn that information into timely, personalized engagement. In this episode of Fierce Pharma’s “The Top Line,” ZS leaders discuss how connected patient data, AI and ZAIDYN can help teams anticipate barriers, support faster intervention and improve patient engagement across the care journey.

Medical affairs is evolving faster than ever. As scientific innovation accelerates, healthcare professionals have instant access to information, and AI is reshaping decision-making, medical affairs teams must move beyond collecting insights to driving real-world impact.

In this sponsored episode of The Top Line by Fierce Pharma, host Irena Luo is joined by Josh "JZ" Schwartz, Vice President of North America Medical Affairs at BeOne Medicines, and Jalpa Shah, Leader in the Medical & Evidence Practice at ZS, to discuss how leading organizations are transforming medical affairs for the future.

In this episode, you'll learn:

•  Why medical affairs has become a critical business driver 
•  How AI is helping teams turn scientific insights into faster, smarter decisions 
•  The shift from measuring activity to measuring clinical impact 
•  Why connected data and continuous prioritization are essential for success 
•  How scientific engagement is changing in the age of AI 
•  What capabilities medical affairs leaders need to thrive over the next few years 

Whether you're leading medical affairs, commercial strategy, or digital transformation, this conversation offers practical insights into building an operating model that keeps pace with today's rapidly evolving healthcare landscape.

Guests:

• Josh "JZ" Schwartz – Vice President, North America Medical Affairs, BeOne Medicines 
• Jalpa Shah – Leader, Medical & Evidence Practice, ZS

Sponsored by ZS | Powered by ZAIDYN™

Learn more about ZAIDYN here

Emerging biopharma companies face unique technology decisions as they prepare for launch. With growing expectations for AI-enabled decision-making, organizations must balance innovation with the realities of limited resources, regulatory complexity and evolving commercial needs.

In the inaugural episode of ZAIDYN Insights, host Kelly Hogan is joined by JR Raelin, Executive Director of Analytics and Insight at SynOx Therapeutics, and Krishna GS, Business Technology Solutions Manager at ZS, to discuss how emerging organizations can build a future-ready technology roadmap powered by connected data and agentic AI.

The conversation explores the importance of establishing strong data foundations before adopting AI, avoiding fragmented technology investments, and creating interoperable platforms that support commercial, medical and patient-focused teams. The guests also share practical guidance for implementation during the first 60–90 days, along with strategies for scaling technology as organizations grow.

Whether you're preparing for your first product launch or planning for long-term portfolio growth, this episode offers practical insights into building a technology ecosystem that transforms data into confident decisions.

 Learn more about how ZAIDYN helps life sciences organizations connect data, decisions and execution: https://bit.ly/3RnYJGD